Anixa Biosciences, Inc. (ANIX)
2.775
+0.02
(+0.91%)
USD |
NASDAQ |
Sep 11, 16:00
2.775
0.00 (0.00%)
After-Hours: 16:28
Anixa Biosciences Gross Profit (TTM) : -0.039M for July 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.039M |
| April 30, 2026 | -0.038M |
| January 31, 2026 | -0.037M |
| October 31, 2025 | -0.036M |
| July 31, 2025 | -0.036M |
| April 30, 2025 | -0.03M |
| January 31, 2025 | -0.033M |
| October 31, 2024 | -0.037M |
| July 31, 2024 | -0.04M |
| April 30, 2024 | -0.048M |
| January 31, 2024 | 0.162M |
| October 31, 2023 | 0.164M |
| July 31, 2023 | 0.165M |
| April 30, 2023 | 0.166M |
| January 31, 2023 | -0.043M |
| October 31, 2022 | -0.042M |
| July 31, 2022 | -0.0469M |
| April 30, 2022 | -0.0521M |
| January 31, 2022 | -0.0557M |
| October 31, 2021 | 0.0818M |
| July 31, 2021 | 0.0841M |
| April 30, 2021 | 0.0527M |
| January 31, 2021 | 0.0527M |
| October 31, 2020 | -0.0902M |
| July 31, 2020 | -0.0912M |
| Date | Value |
|---|---|
| April 30, 2020 | -0.1013M |
| January 31, 2020 | -0.1285M |
| October 31, 2019 | -0.3706M |
| July 31, 2019 | -0.4446M |
| April 30, 2019 | -0.3478M |
| January 31, 2019 | -0.1379M |
| October 31, 2018 | 0.0128M |
| July 31, 2018 | 0.0089M |
| April 30, 2018 | 0.0981M |
| January 31, 2018 | -0.162M |
| October 31, 2017 | -0.1471M |
| July 31, 2017 | 0.0145M |
| April 30, 2017 | -0.1578M |
| January 31, 2017 | -0.147M |
| October 31, 2016 | -0.1403M |
| July 31, 2016 | -0.2909M |
| April 30, 2016 | -0.2831M |
| January 31, 2016 | -0.2731M |
| October 31, 2015 | 8.777M |
| July 31, 2015 | 9.204M |
| April 30, 2015 | 10.18M |
| January 31, 2015 | 10.74M |
| October 31, 2014 | 1.674M |
| July 31, 2014 | 1.534M |
| April 30, 2014 | 0.5901M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.117B |
| Vicapsys Life Sciences, Inc. | 0.00 |